http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2094845-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_671d008452921a0d439716af976cadae
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
filingDate 2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a81a55ee96ea5aa4e9247e21eeb307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85b2a32b4a5ccaafa99b9eaca34aeab4
publicationDate 2009-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2094845-A1
titleOfInvention Artificial binding proteins based on a modified alpha helical region of ubiquitin
abstract The present invention is directed to a method for the generation of binding proteins derived from the protein superfamily of ubiquitin like proteins with modifications in their alpha helical region as well as to a protein obtainable by said method. Furthermore, the invention provides the use of a protein for the specific recognition, binding and neutralization of a predescribed target molecule, for the detection, quantitative determination, separation and/or for the isolation of a corresponding binding partner and the use of a protein of the invention, for diagnosis, prophylaxis and treatment of diseases in which the corresponding binding partner is directly or indirectly involved.
priorityDate 2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136228930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3290

Total number of triples: 34.